CWM
ELV icon

Cranbrook Wealth Management’s Elevance Health ELV Stock Holding History

Cranbrook Wealth Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10
Closed -$4K – 379
2021
Q3 		$4K Buy
+10
New +$3.8K ﹤0.01% 350
2019
Q4 		– Sell
-122
Closed -$29K – 265
2019
Q3 		$29K Buy
+122
New +$33.4K 0.01% 158

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Cranbrook Wealth Management's ELV Position: Q4 2021 in Review

Cranbrook Wealth Management sold out of Elevance Health (ELV) in Q4 2021, closing a stake of 10 shares — an estimated $4K sold.

Cranbrook Wealth Management first reported a position in ELV in Q3 2019 and held it in 2 quarters. The position peaked at $29K in Q3 2019. 1,372 funds tracked by Wall St. Rank hold ELV as of Q4 2021.

  • Cranbrook Wealth Management reported no remaining Elevance Health position as of Q4 2021 after selling out during the quarter.
  • Cranbrook Wealth Management sold 10 Elevance Health shares in Q4 2021, an estimated $4K.
  • Cranbrook Wealth Management first reported a position in Elevance Health in Q3 2019 and held it in 2 quarters.
  • Cranbrook Wealth Management's Elevance Health position peaked at $29K in Q3 2019.
  • 1,372 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.

Based on Cranbrook Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.